Humana Quarterly Income Statement
NYSE: HUMHealthcareHealthcare PlansUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Humana revenue and earnings
In the quarter ended Mar 31, 2026, Humana generated $39.65 billion in revenue, up 23.5% from the same quarter a year earlier. Net income was $1.19 billion (-4.7% year over year), for a net margin of 3.0% versus a median of 0.6% in the prior 5 quarters. Operating margin was 4.4%.
Diluted earnings per share came in at $9.83, down from $10.30.
Summary generated from market data by MetaCap's automated system. Methodology
Humana income statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.65B | 32.52B | 32.65B | 32.39B | 32.11B | 29.21B | 29.40B | 29.54B | 29.61B | 26.46B | 26.42B | 26.75B |
| Revenue growth (YoY) | +23.47% | +11.30% | +11.06% | +9.64% | +8.45% | +10.40% | +11.26% | +10.44% | +10.73% | +17.93% | +15.90% | +13.04% |
| Operating Expenses | 37.89B | 33.32B | 32.25B | 31.29B | 30.10B | 29.76B | 28.67B | 28.40B | 28.38B | 26.81B | 25.22B | 25.31B |
| Selling, General & Admin | 4.02B | 4.44B | 4.08B | 3.55B | 3.38B | 4.17B | 3.34B | 3.15B | 3.04B | 3.83B | 3.27B | 3.11B |
| Operating Income | 1.75B | -808.00M | 400.00M | 1.10B | 2.01B | -543.00M | 728.00M | 1.14B | 1.24B | -348.00M | 1.21B | 1.44B |
| Interest Expense | 193.00M | 146.00M | 168.00M | 157.00M | 160.00M | 164.00M | 169.00M | 168.00M | 159.00M | 146.00M | 114.00M | 120.00M |
| Other Income (Expense) | 34.00M | -53.00M | -35.00M | -200.00M | -163.00M | -155.00M | 92.00M | -55.00M | -63.00M | -97.00M | 6.00M | -54.00M |
| Pretax Income | 1.59B | -1.01B | 134.00M | 741.00M | 1.69B | -906.00M | 635.00M | 901.00M | 990.00M | -610.00M | 1.09B | 1.25B |
| Income Tax | 395.00M | -249.00M | -86.00M | 179.00M | 406.00M | -216.00M | 155.00M | 223.00M | 251.00M | -75.00M | 256.00M | 296.00M |
| Net Income | 1.19B | -796.00M | 195.00M | 545.00M | 1.24B | -693.00M | 480.00M | 679.00M | 741.00M | -541.00M | 832.00M | 959.00M |
| Net Income growth (YoY) | -4.66% | — | -59.38% | -19.73% | +67.88% | — | -42.31% | -29.20% | -40.19% | — | -30.38% | +37.79% |
| EPS (Basic) | 9.85 | -6.58 | 1.62 | 4.52 | 10.31 | -5.74 | 3.99 | 5.63 | 6.13 | -4.26 | 6.74 | 7.70 |
| EPS (Diluted) | 9.83 | -6.59 | 1.62 | 4.51 | 10.30 | -5.73 | 3.98 | 5.62 | 6.11 | -4.24 | 6.71 | 7.66 |
| Shares Outstanding (Basic) | 120.33M | — | 120.27M | 120.54M | 120.67M | — | 120.41M | 120.44M | 120.98M | — | 123.43M | 124.57M |
| Shares Outstanding (Diluted) | 120.65M | — | 120.75M | 120.75M | 120.84M | — | 120.76M | 120.67M | 121.27M | — | 123.98M | 125.11M |
| EBITDA | 1.92B | -644.00M | 573.00M | 1.28B | 2.20B | -335.00M | 938.00M | 1.35B | 1.45B | -147.00M | 1.41B | 1.63B |
| Operating Margin | 4.42% | -2.49% | 123.00% | 3.39% | 6.27% | -1.86% | 2.48% | 3.86% | 4.17% | -132.00% | 4.56% | 5.37% |
| Net Margin | 2.99% | -2.45% | 60.00% | 1.68% | 3.87% | -2.37% | 1.63% | 2.30% | 2.50% | -2.04% | 3.15% | 3.59% |
This table shows 12 quarterly periods of Humana's income statement, from Q1 2026 back to Q2 2023, across 16 line items including revenue, operating expenses, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow HUM's reporting calendar. What is a income statement?